GS0051: PHARMACEUTICAL PRODUCTS FOR DIAGNOSTIC AND THERAPEUTIC USE, NAMELY, ARTIFICIAL BLOOD SUBSTITUTES, CONTRAST AND IMAGING AGENTS, OXYGEN TRANSPORT PREPARATIONS IN THE NATURE OF LIQUID ADMINISTERED TO THE BODY TO DELIVER OXYGEN TO TISSUES, MICROSCOPIC PREPARATIONS FOR ENCASING DRUGS FOR USE AS A DRUG DELIVERY PLATFORM FOR DELIVERY TO THE LUNGS AND OTHER AREAS OF THE BODY, THERMOREVERSIBLE GELS FOR USE IN DRUG DELIVERY AND FOR REDUCING POST-SURGICAL ADHESIONS
PM0000: ALLIANCE PHARMACEUTICAL CORPORATION
Case File Event Statements
1/31/2010 - 14 years ago
18 - CANCELLED SEC. 8 (6-YR)Type:C8..
1/23/2008 - 16 years ago
17 - CASE FILE IN TICRSType:CFIT
6/24/2003 - 21 years ago
16 - REGISTERED-PRINCIPAL REGISTERType:R.PR
4/1/2003 - 21 years ago
15 - PUBLISHED FOR OPPOSITIONType:PUBO
3/12/2003 - 21 years ago
14 - NOTICE OF PUBLICATIONType:NPUB
1/30/2003 - 21 years ago
13 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/28/2003 - 21 years ago
12 - ASSIGNED TO EXAMINERType:DOCK
7/30/2002 - 22 years ago
11 - LETTER OF SUSPENSION MAILEDType:CNSL
7/1/2002 - 22 years ago
10 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
7/15/2002 - 22 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
7/1/2002 - 22 years ago
8 - PAPER RECEIVEDType:MAIL
1/23/2002 - 22 years ago
7 - NON-FINAL ACTION MAILEDType:CNRT
12/7/2001 - 23 years ago
6 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
7/23/2001 - 23 years ago
5 - LETTER OF SUSPENSION MAILEDType:CNSL
4/30/2001 - 23 years ago
4 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA